Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models
- 20 May 2003
- Vol. 21 (25-26) , 3854-3862
- https://doi.org/10.1016/s0264-410x(03)00328-1
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Role of Alpha/Beta Interferon in Venezuelan Equine Encephalitis Virus Pathogenesis: Effect of an Attenuating Mutation in the 5′ Untranslated RegionJournal of Virology, 2001
- Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN miceVaccine, 1997
- Virulent and attenuated mutant Venezuelan equine encephalitis virus show marked differences in replication in infection in murine macrophagesMicrobial Pathogenesis, 1996
- Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccineVaccine, 1996
- Mechanism of Neuroinvasion of Venezuelan Equine Encephalitis Virus in the MouseVirology, 1995
- Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: Construction of single and multiple mutants in a full-length cDNA cloneVirology, 1991
- In vitro synthesis of infectious venezuelan equine encephalitis virus RNA from a cDNA clone: Analysis of a viable deletion mutantVirology, 1989
- The Attenuation of Poliovirus NeurovirulenceAnnual Review of Microbiology, 1987
- Sindbis Virus Mutants Selected for Rapid Growth in Cell Culture Display Attenuated Virulence in AnimalsScience, 1984
- Experimental Infection of Horses with Enzootic and Epizootic Strains of Venezuelan Equine Encephalomyelitis VirusThe Journal of Infectious Diseases, 1973